N-acetylsphingosine

N-acetylsphingosine is a lipid of Sphingolipids (SP) class. N-acetylsphingosine is associated with abnormalities such as Morphologically altered structure, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and Gigantism. The involved functions are known as inhibitors, anti-apoptosis, Apoptosis, Dephosphorylation and immunoreactivity. N-acetylsphingosine often locates in Plasma membrane, Mitochondria, Pore, Membrane and Cytoplasmic matrix. The associated genes with N-acetylsphingosine are EGR3 gene, CFB gene, FATE1 gene, P4HTM gene and PFDN4 gene. The related lipids are Sphingolipids, Cardiolipins, Glycerophospholipids, dihydroceramide and Phosphatidic Acid.

Cross Reference

Introduction

To understand associated biological information of N-acetylsphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with N-acetylsphingosine?

N-acetylsphingosine is suspected in Morphologically altered structure, protrusion, DERMATITIS HERPETIFORMIS, FAMILIAL, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with N-acetylsphingosine

MeSH term MeSH ID Detail
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Retinoblastoma D012175 12 associated lipids
Parkinson Disease D010300 53 associated lipids
Neuronal Ceroid-Lipofuscinoses D009472 5 associated lipids
Nerve Degeneration D009410 53 associated lipids
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Lung Neoplasms D008175 171 associated lipids
Leukemia D007938 74 associated lipids
Insulin Resistance D007333 99 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Glioma D005910 112 associated lipids
Fever D005334 35 associated lipids
Eye Abnormalities D005124 7 associated lipids
Per page 10 20 50 | Total 26

PubChem Associated disorders and diseases

What pathways are associated with N-acetylsphingosine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with N-acetylsphingosine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with N-acetylsphingosine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with N-acetylsphingosine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with N-acetylsphingosine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with N-acetylsphingosine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with N-acetylsphingosine

Download all related citations
Per page 10 20 50 100 | Total 506
Authors Title Published Journal PubMed Link
Gutwein P et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. 2005 Clin. Cancer Res. pmid:15814625
Takai N et al. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma. 2005 Oncol. Rep. pmid:16211298
Jang GJ et al. C2-ceramide induces vasodilation in phenylephrine-induced pre-contracted rat thoracic aorta: role of RhoA/Rho-kinase and intracellular Ca2+ concentration. 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16231160
Arboleda G et al. Metabolic activity: a novel indicator of neuronal survival in the murine dopaminergic cell line CAD. 2005 J. Mol. Neurosci. pmid:16055947
Giltiay NV et al. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes. 2005 J. Lipid Res. pmid:16106045
Falluel-Morel A et al. Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15695581
Kim SH et al. Induction of apoptosis in chicken oviduct cells by C2-ceramide. 2005 Mol. Cells pmid:15879700
Townley HE et al. Ceramides induce programmed cell death in Arabidopsis cells in a calcium-dependent manner. 2005 Biol. Chem. pmid:15843160
Goswami R et al. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. 2005 J. Neurosci. Res. pmid:15968641
Yabu T et al. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. 2005 Blood pmid:15741222
Sot J et al. Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides. 2005 Biochim. Biophys. Acta pmid:15904658
Hampel B et al. Differential regulation of apoptotic cell death in senescent human cells. 2004 Nov-Dec Exp. Gerontol. pmid:15582287
Suzuki E et al. Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15466700
d'Anglemont de Tassigny A et al. Volume-sensitive chloride channels (ICl,vol) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes. 2004 Fundam Clin Pharmacol pmid:15482374
Park HW et al. Enhancement of radiosensitivity by combined ceramide and dimethylsphingosine treatment in lung cancer cells. 2004 Exp. Mol. Med. pmid:15557813
Schultz A and Larsson C Ceramide influences neurite outgrowth and neuroblastoma cell apoptosis regulated by novel protein kinase C isoforms. 2004 J. Neurochem. pmid:15189345
Cao LC et al. Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. 2004 Kidney Int. pmid:15496160
Park IN et al. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression. 2004 Drug Metab. Dispos. pmid:15319326
Hatano M et al. Enhancement of C2-ceramide antitumor activity by small interfering RNA on X chromosome-linked inhibitor of apoptosis protein in resistant human glioma cells. 2004 J. Neurosurg. pmid:15255262
Daido S et al. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. 2004 Cancer Res. pmid:15205343